All Cosmos Bio-Tech Holding Corp
TWSE:4148
Intrinsic Value
All Cosmos Bio-Tech Holding Corp. engages in the manufacture, distribute, research and development of bio-organic and bio-chemical fertilizers. [ Read More ]
The intrinsic value of one
All Cosmos Bio-Tech Holding Corp
stock under the Base Case scenario is
48.49
TWD.
Compared to the current market price of 50.9 TWD,
All Cosmos Bio-Tech Holding Corp
is
Overvalued by 5%.
All Cosmos Bio-Tech Holding Corp's market capitalization is 3.3B TWD.
All Cosmos Bio-Tech Holding Corp stock price is 50.9 TWD.
All Cosmos Bio-Tech Holding Corp stock (48.49 TWD) is 5% less than its price (50.9 TWD).
All Cosmos Bio-Tech Holding Corp stock price (50.9 TWD) is 15% less than its DCF Value (60.11 TWD). Open DCF Valuation
All Cosmos Bio-Tech Holding Corp stock (36.86 TWD) is 28% less than its price (50.9 TWD). Open Relative Valuation
All Cosmos Bio-Tech Holding Corp has upside potential of 91% compared to the average analyst price target.
Open Wall St Estimates
All Cosmos Bio-Tech Holding Corp's ROE (Return on Equity) has decreased in the last 3 years from 7% to 6%.
All Cosmos Bio-Tech Holding Corp's ROIC (Return on Invested Capital) has decreased in the last 3 years from 8% to 6%.
All Cosmos Bio-Tech Holding Corp has positive Free Cash Flow for the last twelve months.
All Cosmos Bio-Tech Holding Corp has positive three-year average ROE (Return on Equity): 11%. The company is efficient at transforming stockholders' equity into net income.
All Cosmos Bio-Tech Holding Corp has positive Operating Income for the last twelve months.
All Cosmos Bio-Tech Holding Corp has positive Net Income for the last twelve months.
All Cosmos Bio-Tech Holding Corp has positive three-year average ROIC (Return on Invested Capital): 12%. The company is efficient at using invested capital to generate operating income.
All Cosmos Bio-Tech Holding Corp's ROE (Return on Equity) for the past 12 months is positive and is equal to 6%.
All Cosmos Bio-Tech Holding Corp's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 6%.
All Cosmos Bio-Tech Holding Corp has positive Gross Profit for the last twelve months.
All Cosmos Bio-Tech Holding Corp's Revenue has dropped by 24% over the past 12 months.
All Cosmos Bio-Tech Holding Corp's Revenue has been growing by 20% per year for the last 3 years.
All Cosmos Bio-Tech Holding Corp's Altman Z-Score is equal to 2.94.
All Cosmos Bio-Tech Holding Corp's long-term assets (4B TWD) exceed its long-term liabilties (1B TWD).
All Cosmos Bio-Tech Holding Corp's short-term assets (3B TWD) exceed its short-term liabilties (790m TWD).
All Cosmos Bio-Tech Holding Corp's D/E (Debt to Equity) is very low and is equal to 0.01.
All Cosmos Bio-Tech Holding Corp has negative Net Debt. This means that the company has more cash and short-term investments (2B TWD) than debt (30m TWD).
All Cosmos Bio-Tech Holding Corp earns more than enough operating income (190m TWD) to safely cover interest payments on its debt (3m TWD).
Valuation Backtest
All Cosmos Bio-Tech Holding Corp
Run backtest to discover the historical profit from buying and selling
All Cosmos Bio-Tech Holding Corp
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
All Cosmos Bio-Tech Holding Corp
Balance Sheet Decomposition
All Cosmos Bio-Tech Holding Corp
| Current Assets | 2.8B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 504.7m |
| Other Current Assets | 742.7m |
| Non-Current Assets | 855.4m |
| Long-Term Investments | 22.3m |
| PP&E | 803.3m |
| Intangibles | 10.2m |
| Other Non-Current Assets | 19.5m |
| Current Liabilities | 790.2m |
| Accounts Payable | 131m |
| Accrued Liabilities | 68m |
| Other Current Liabilities | 591.3m |
| Non-Current Liabilities | 629.1m |
| Long-Term Debt | 29.9m |
| Other Non-Current Liabilities | 599.3m |
Earnings Waterfall
All Cosmos Bio-Tech Holding Corp
|
Revenue
|
2.8B
TWD
|
|
Cost of Revenue
|
-2.2B
TWD
|
|
Gross Profit
|
588m
TWD
|
|
Operating Expenses
|
-398.1m
TWD
|
|
Operating Income
|
189.9m
TWD
|
|
Other Expenses
|
-50.5m
TWD
|
|
Net Income
|
139.4m
TWD
|
Free Cash Flow Analysis
All Cosmos Bio-Tech Holding Corp
Profitability Score
Profitability Due Diligence
All Cosmos Bio-Tech Holding Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
All Cosmos Bio-Tech Holding Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
All Cosmos Bio-Tech Holding Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
All Cosmos Bio-Tech Holding Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
All Cosmos Bio-Tech Holding Corp
According to Wall Street analysts, the average 1-year price target for
All Cosmos Bio-Tech Holding Corp
is 97 TWD
.
Shareholder Return
Price
All Cosmos Bio-Tech Holding Corp
| Average Annual Return | 6.69% |
| Standard Deviation of Annual Returns | 22.14% |
| Max Drawdown | -67% |
| Market Capitalization | 3.3B TWD |
| Shares Outstanding | 64 034 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
All Cosmos Bio-Tech Holding Corp
Country
Industry
Market Cap
Dividend Yield
Description
All Cosmos Bio-Tech Holding Corp. engages in the manufacture, distribute, research and development of bio-organic and bio-chemical fertilizers. The company is headquartered in Pasir Gudang, Johor. The company went IPO on 2017-06-08. The firm operates through its wholly owned subsidiary, All Cosmos Industries Sdn Bhd (ACI) is engaged in a range of industries, mainly divided into four areas, including agriculture, waste reutilization, health care and pharmaceutical, research and development of microbials. Its bio-chemical fertilizers are principally engaged in microbial research and developing, manufacturing and sales of bio-organic and biochemical fertilizers, and agriculture-related activities through the use of technology. The Company, through Grape King Bio, is engaged in health supplement manufacturing in Taiwan. Its waste reutilization companies include Sawit Ecoshield Sdn. Bhd., and Kinabalu Life Sciences Sdn Bhd. The Company, through Arif Efektif Sdn. Bhd. uses ranges of biotechnology to control bacteria and other microorganisms. The company also produces a range of industrial microbes, fungal and virus.
Contact
IPO
Employees
Officers
The intrinsic value of one
All Cosmos Bio-Tech Holding Corp
stock under the Base Case scenario is
48.49
TWD.
Compared to the current market price of 50.9 TWD,
All Cosmos Bio-Tech Holding Corp
is
Overvalued by 5%.
You don't have any saved screeners yet
